Lupin Limited said that it has been issued the establishment inspection report (EIR) from the US Food and Drug Administration (US FDA) for its manufacturing facility in Goa following an inspection in September 2021. The US FDA determined that the inspection classification of the Goa manufacturing facility is voluntary action indicated (VAI). Voluntary Action Indicated […]
Lupin Limited has launched its diagnostics business in India under the name Lupin Diagnostics as part of its efforts to offer integrated healthcare in India. Lupin Diagnostics, which is a fully-owned subsidiary of Lupin has formally begun operations. It has set up a 45,000 sft national reference laboratory in Navi Mumbai. With high-quality equipment, experienced […]
Indian pharma company Lupin Limited has secured a non-exclusive license from TB Alliance, a non-profit drug developer, for manufacturing the anti-TB drug pretomanid. Pretomanid is part of the three-drug BPaL regimen (made up of bedaquiline, pretomanid, and linezolid), intended for the treatment of highly drug-resistant tuberculosis (TB). Mel Spigelman — President and CEO of TB […]